Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

NCT: NCT04703166 · RECRUITING

NCT IDNCT04703166

StatusRECRUITING

Start Date2025-04-08

SponsorTulane University School of Medicine (OTHER)

First posted2021-01-11

Last updated2026-10-20

Brief Summary

To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑